InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-41.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Molineaux Christopher, Directeur. Director active across 1 company, notably Calithera Biosciences, Inc.. Cumulatively, 4 reports have been logged. Split: 1 buy · 0 sell. Activity tracked since 27 October 2021. The latest transaction was disclosed on 23 January 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
217 shares@ US$0.44610.1% of flowCommon StockSEC:0000899243-23-002608:0
100,000 shares@ €0.730250.0% of flowCommon StockSEC:0000899243-21-044145:0
Ideal exit: 7 Aug 2022 (T+270)
12,000 shares0Common StockSEC:0000899243-21-043692:0
36,000 shares0Common StockSEC:0000899243-21-042069:0
4 of 4 declarations
About Molineaux Christopher
Molineaux Christopher is SR. VP of development at Calithera Biosciences, Inc., a biopharmaceutical company. He oversees development initiatives and contributes to innovation in the sector.
